Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03002441 · ClinicalTrials.gov registry record · NA
Same-day Cervical Preparation Before Dilation and Evacuation
A NA study, sponsored by Planned Parenthood of Greater New York.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT03002441: Completed NA study, sponsored by Planned Parenthood of Greater New York.
NCT03002441 is a NA study that has completed, run by Planned Parenthood of Greater New York. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03002441, a NA study, has completed, sponsored by Planned Parenthood of Greater New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this randomized trial is to compare same-day cervical preparation using Dilapan-S™ plus buccal misoprostol to overnight cervical preparation using Dilapan-S™ before D\&E at 16.0 to 20.0 weeks. Primary objective: To compare D\&E operative time. We hypothesize that same-day Dilapan-S™ plus buccal misoprostol is non-inferior to overnight Dilapan-S™ with respect to operative time. Secondary objectives: To compare treatment groups for the following: Pre-operative cervical dilation; need for mechanical dilation and ease of dilation if required; ability to complete D\&E without further cervical preparation; ease of D\&E; complications; pain; side effects; patient and provider satisfaction.
Interventions
- DEVICE Same-Day Dilapan-S
- DEVICE Overnight Dilapan-S
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2016-12 |
| Est. Completion | 2020-02-28 |
| Phase | NA |
What the finished NCT03002441 record still lists
NCT03002441 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Same-Day Dilapan-S is the first listed.
NCT03002441 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03002441 about?
NCT03002441 is a clinical study titled "Same-day Cervical Preparation Before Dilation and Evacuation". The purpose of this randomized trial is to compare same-day cervical preparation using Dilapan-S™ plus buccal misoprostol to overnight cervical preparation using Dilapan-S™ before D\&E at 16.0 to 20.0 weeks. Primary objective: To compare D\&E operative time. We hypothesize that same-day Dilapan-S™ ...
What is the current status of trial NCT03002441?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2016-12. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT03002441?
The interventions under investigation include: Same-Day Dilapan-S (DEVICE), Overnight Dilapan-S (DEVICE).
Who is sponsoring clinical trial NCT03002441?
This trial is sponsored by Planned Parenthood of Greater New York, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03002441's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia